chr16-15598974-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_014647.4(MARF1):c.4864G>A(p.Val1622Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000738 in 1,611,916 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014647.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MARF1 | NM_014647.4 | c.4864G>A | p.Val1622Ile | missense_variant | 26/27 | ENST00000396368.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MARF1 | ENST00000396368.8 | c.4864G>A | p.Val1622Ile | missense_variant | 26/27 | 1 | NM_014647.4 | P5 |
Frequencies
GnomAD3 genomes AF: 0.0000594 AC: 9AN: 151534Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000933 AC: 23AN: 246572Hom.: 0 AF XY: 0.000149 AC XY: 20AN XY: 133824
GnomAD4 exome AF: 0.0000753 AC: 110AN: 1460266Hom.: 0 Cov.: 32 AF XY: 0.0000895 AC XY: 65AN XY: 726380
GnomAD4 genome AF: 0.0000593 AC: 9AN: 151650Hom.: 0 Cov.: 31 AF XY: 0.0000675 AC XY: 5AN XY: 74110
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 18, 2023 | The c.4864G>A (p.V1622I) alteration is located in exon 26 (coding exon 25) of the KIAA0430 gene. This alteration results from a G to A substitution at nucleotide position 4864, causing the valine (V) at amino acid position 1622 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at